Medical Prognosis Institute

Improve cancer treatment using leading edge technology based on DNA microarrays

Medical Prognosis Institute was founded in order to address the need of patients, care givers and healthcare professionals to use individualised genomic profiling of tumour tissue for determining which cancer patients will benefit from which specific chemotherapy and/or radiation therapy.

Jesper Drejet (CEO, President)
Steen Knudsen (CSO)

Frank Knudsen (Chairman)
Niels Johansen
Jørgen Søberg Petersen

Agern Allé 7, 1.
2970 Hørsholm
Denmark
Phone: +45-45 81 19 26